Femar 2.5 mg נורווגיה - נורבגית - Statens legemiddelverk

femar 2.5 mg

abacus medicine a/s - letrozol - tablett, filmdrasjert - 2.5 mg

Femar 2.5 mg נורווגיה - נורבגית - Statens legemiddelverk

femar 2.5 mg

abacus medicine a/s - letrozol - tablett, filmdrasjert - 2.5 mg

Diacomit 250 mg נורווגיה - נורבגית - Statens legemiddelverk

diacomit 250 mg

abacus medicine a/s - stiripentol - kapsel, hard - 250 mg

Diacomit 500 mg נורווגיה - נורבגית - Statens legemiddelverk

diacomit 500 mg

abacus medicine a/s - stiripentol - kapsel, hard - 500 mg

Adempas 0.5 mg נורווגיה - נורבגית - Statens legemiddelverk

adempas 0.5 mg

abacus medicine a/s - riociguat - tablett, filmdrasjert - 0.5 mg

Adempas 1 mg נורווגיה - נורבגית - Statens legemiddelverk

adempas 1 mg

abacus medicine a/s - riociguat - tablett, filmdrasjert - 1 mg

Adempas 1.5 mg נורווגיה - נורבגית - Statens legemiddelverk

adempas 1.5 mg

abacus medicine a/s - riociguat - tablett, filmdrasjert - 1.5 mg

Adempas 2 mg נורווגיה - נורבגית - Statens legemiddelverk

adempas 2 mg

abacus medicine a/s - riociguat - tablett, filmdrasjert - 2 mg

Adempas 2.5 mg נורווגיה - נורבגית - Statens legemiddelverk

adempas 2.5 mg

abacus medicine a/s - riociguat - tablett, filmdrasjert - 2.5 mg

Thiotepa Riemser האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.